Aditus Laboratories Profile
Key Indicators
- Authorised Capital ₹ 6.90 M
as on 03-01-2025
- Paid Up Capital ₹ 6.90 M
as on 03-01-2025
- Company Age 21 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.42 Cr
as on 03-01-2025
- Satisfied Charges ₹ 1.19 Cr
as on 03-01-2025
About Aditus Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.90 M and a paid-up capital of Rs 6.90 M.
The company currently has active open charges totaling ₹5.42 Cr. The company has closed loans amounting to ₹1.19 Cr, as per Ministry of Corporate Affairs (MCA) records.
Balamani Vakiti, Harish Vakiti, Bakka Ashwini, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24239TG2003PLC042139
- Company No.
042139
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
27 Nov 2003
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Aditus Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sriharsha Akshanthala  | Managing Director | 08-Jun-2022 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Balamani Vakiti | Additional Director | 30-Aug-2023 | Current |
| Harish Vakiti | Additional Director | 30-Aug-2023 | Current |
| Bakka Ashwini | Additional Director | 30-Aug-2023 | Current |
| Suresh Vakiti | Additional Director | 30-Aug-2023 | Current |
Financial Performance of Aditus Laboratories.
Enhance accessibility to Aditus Laboratories's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Aditus Laboratories?
Unlock access to Aditus Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 08 Dec 2023 | ₹5.42 Cr | Open |
State Bank Of India Creation Date: 25 Feb 2020 | ₹3.60 M | Satisfied |
State Bank Of India Creation Date: 22 Jan 2013 | ₹0.40 M | Satisfied |
How Many Employees Work at Aditus Laboratories?
Unlock and access historical data on people associated with Aditus Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aditus Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aditus Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
